Article ; Online: Impact of a digital web-based asthma platform, a real-life study.
2023 Volume 23, Issue 1, Page(s) 165
Abstract: Background: Digital health technology (DHT) is a growing area in the treatment of chronic diseases. Study results on DHT's effect on asthma control have been mixed, but benefits have been seen for adherence, self-management, symptoms, and quality of ... ...
| Abstract | Background: Digital health technology (DHT) is a growing area in the treatment of chronic diseases. Study results on DHT's effect on asthma control have been mixed, but benefits have been seen for adherence, self-management, symptoms, and quality of life. The aim was to evaluate the impact of an interactive web-based asthma treatment platform on asthma exacerbations and health care visits. Methods: In this real-life study, we retrospectively collected data on adult patients registered on a web-based interactive asthma treatment platform between December 2018 and May 2021. Patients who activated their accounts were active users, and patients who did not were inactive users and considered as controls. We compared the number of exacerbations, total number of exacerbation events defined as the sum of oral corticosteroid (OCS) and antimicrobial courses, emergency room visits, hospitalizations, and asthma-related health care visits before and one year after the registration on the platform. Statistical tests used included the t-test, Pearson's chi-square test and Poisson regression models. Results: Of 147 patients registered on the platform, 106 activated their accounts and 41 did not. The active users had significantly fewer total number of exacerbation events (2.56 per person years, relative decline 0.78, 95% CI 0.6 to 1.0) and asthma-related health care visits (2.38 per person years, relative decline 0.84, 95% CI 0.74 to 0.96) than before registration to the platform, whereas the reductions in health care visits and the total number of exacerbation events were not significant in the inactive users. Conclusions: An interactive web-based asthma platform can reduce asthma-related health care visits and exacerbations when used actively. |
|---|---|
| MeSH term(s) | Adult ; Humans ; Quality of Life ; Retrospective Studies ; Asthma/drug therapy ; Adrenal Cortex Hormones/therapeutic use ; Internet ; Anti-Asthmatic Agents/therapeutic use |
| Chemical Substances | Adrenal Cortex Hormones ; Anti-Asthmatic Agents |
| Language | English |
| Publishing date | 2023-05-12 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 2059871-3 |
| ISSN | 1471-2466 ; 1471-2466 |
| ISSN (online) | 1471-2466 |
| ISSN | 1471-2466 |
| DOI | 10.1186/s12890-023-02467-8 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.